Next Article in Journal
Chromosomal Evolution in Lower Vertebrates: Sex Chromosomes in Neotropical Fishes
Next Article in Special Issue
Alternative Splicing of L-type CaV1.2 Calcium Channels: Implications in Cardiovascular Diseases
Previous Article in Journal
Hybrid Sequencing of Full-Length cDNA Transcripts of Stems and Leaves in Dendrobium officinale
Review

Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools

1
Centro de Investigaciones en Ciencias Microbiológicas, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla CP 72570, Mexico
2
Centro de Investigación Biomédica de Oriente (CIBIOR), Instituto Mexicano del Seguro Social (IMSS), Metepec, Puebla CP 74360, Mexico
3
Centro Universitario de Vinculación, Dirección de Innovación y Transferencia de Conocimiento, Benemérita Universidad Autónoma de Puebla, Puebla CP 72570, Mexico
4
Edificio IC11, Ciudad Universitaria, Col. San Manuel, Puebla CP 72570, Mexico
*
Author to whom correspondence should be addressed.
Current address: Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.
Academic Editor: Michael Ladomery
Genes 2017, 8(10), 217; https://doi.org/10.3390/genes8100217
Received: 28 July 2017 / Revised: 22 August 2017 / Accepted: 22 August 2017 / Published: 5 October 2017
(This article belongs to the Special Issue Aberrant Pre-mRNA Splicing in Disease)
Alternative splicing is a key molecular mechanism now considered as a hallmark of cancer that has been associated with the expression of distinct isoforms during the onset and progression of the disease. The leading cause of cancer-related deaths in women worldwide is breast cancer, and even when the role of alternative splicing in this type of cancer has been established, the function of this mechanism in breast cancer biology is not completely decoded. In order to gain a comprehensive view of the role of alternative splicing in breast cancer biology and development, we summarize here recent findings regarding alternative splicing events that have been well documented for breast cancer evolution, considering its prognostic and therapeutic value. Moreover, we analyze how the response to endocrine and chemical therapies could be affected due to alternative splicing and differential expression of variant isoforms. With all this knowledge, it becomes clear that targeting alternative splicing represents an innovative approach for breast cancer therapeutics and the information derived from current studies could guide clinical decisions with a direct impact in the clinical advances for breast cancer patients nowadays. View Full-Text
Keywords: breast cancer; alternative splicing; prognosis; therapeutics; expression breast cancer; alternative splicing; prognosis; therapeutics; expression
Show Figures

Figure 1

MDPI and ACS Style

Martínez-Montiel, N.; Anaya-Ruiz, M.; Pérez-Santos, M.; Martínez-Contreras, R.D. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools. Genes 2017, 8, 217. https://doi.org/10.3390/genes8100217

AMA Style

Martínez-Montiel N, Anaya-Ruiz M, Pérez-Santos M, Martínez-Contreras RD. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools. Genes. 2017; 8(10):217. https://doi.org/10.3390/genes8100217

Chicago/Turabian Style

Martínez-Montiel, Nancy, Maricruz Anaya-Ruiz, Martín Pérez-Santos, and Rebeca D. Martínez-Contreras. 2017. "Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools" Genes 8, no. 10: 217. https://doi.org/10.3390/genes8100217

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop